Kriya Therapeutics has set up a facility in North Carolina to support the production of its pipeline of AAV-based gene therapies. The site at Research Triangle Park (RTP) will house a process development lab, quality control and analytical development capability, pilot production suite. In addition, the facility will also have a current good manufacturing practice (cGMP) standard production infrastructure for gene therapies. CEO Shankar Ramaswamy told Bioprocess Insider: “By establishing our own internal manufacturing facility, we can help ensure that we have…